Olov Norlen
Overview
Explore the profile of Olov Norlen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klimacek B, Akerstrom T, Anneback M, Hellman P, Norlen O, Stalberg P
Langenbecks Arch Surg
. 2025 Mar;
410(1):90.
PMID: 40047926
Purpose: Small intestinal neuroendocrine tumours (SI-NETs) are the most common malignancy of the small bowel. Curative treatment is surgical, with exploratory laparotomy considered the standard approach. This study aimed to...
2.
Adwall L, Fredriksson I, Hultin H, Mani M, Norlen O
BJS Open
. 2024 Dec;
8(6).
PMID: 39673757
Background: There is conflicting evidence regarding whether postoperative complications after breast cancer surgery are associated with worse oncological outcome. This study aimed to assess the risk of systemic breast cancer...
3.
Van Den Heede K, Van Beek D, Van Slycke S, Borel Rinkes I, Norlen O, Stalberg P, et al.
Br J Surg
. 2024 Apr;
111(4).
PMID: 38626261
Background: Small bowel neuroendocrine tumours often present with locally advanced or metastatic disease. The aim of this paper is to provide evidence-based recommendations regarding (controversial) topics in the surgical management...
4.
Van Beek D, Van Den Heede K, Borel Rinkes I, Norlen O, Van Slycke S, Stalberg P, et al.
Br J Surg
. 2024 Feb;
111(2).
PMID: 38364061
No abstract available.
5.
Anneback M, Osterman C, Arlebrink J, Mellerstedt S, Papathanasakis N, Wallin G, et al.
Br J Surg
. 2023 Nov;
111(1).
PMID: 37995259
Background: A previous nationwide study from Sweden showed that the rate of permanent hypoparathyroidism is high and under-rated in the Swedish Quality Register. This retrospective population-based study aimed to validate...
6.
Kjaer J, Clancy T, Thornell A, Andersson N, Hellman P, Crona J, et al.
Ann Surg Open
. 2023 Aug;
3(1):e151.
PMID: 37600107
Objective: To determine the association of primary tumor resection in stage IV pancreatic neuroendocrine tumors (Pan-NET) and survival in a propensity-score matched study. Background: Pan-NET are often diagnosed with stage...
7.
Kjaer J, Norlen O, Hellman P, Stalberg P
World J Surg
. 2023 Feb;
47(4):1086.
PMID: 36757425
No abstract available.
8.
Kjaer J, Norlen O, Hellman P, Stalberg P
World J Surg
. 2023 Jan;
47(4):1084-1085.
PMID: 36705741
No abstract available.
9.
Adwall L, Hultin H, Mani M, Norlen O
J Oncol
. 2022 Dec;
2022:6601066.
PMID: 36568639
Background: Surgical site infection (SSI) is a well-known complication after breast cancer surgery. The primary aim was to assess risk factors for SSI. Risk factors for other wound complications were...
10.
Kjaer J, Smith S, Hellman P, Stalberg P, Crona J, Welin S, et al.
World J Surg
. 2022 Sep;
47(2):340-347.
PMID: 36175647
Background: The use of liver transplantation (LT) in patients with stage IV neuroendocrine pancreatic tumors (pan-NET) is under debate. Previous studies report a 5-year survival of 27-53% after LT in...